1. Home
  2. ONB vs DVA Comparison

ONB vs DVA Comparison

Compare ONB & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONB

Old National Bancorp

HOLD

Current Price

$23.43

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$150.94

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONB
DVA
Founded
1834
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
10.1B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
ONB
DVA
Price
$23.43
$150.94
Analyst Decision
Buy
Hold
Analyst Count
12
4
Target Price
$26.83
$156.75
AVG Volume (30 Days)
2.7M
1.3M
Earning Date
01-01-0001
05-04-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
9.84
Revenue
N/A
$13,643,069,000.00
Revenue This Year
$27.88
$3.80
Revenue Next Year
$5.00
$3.04
P/E Ratio
$13.92
$15.51
Revenue Growth
N/A
6.46
52 Week Low
$16.83
$101.00
52 Week High
$26.17
$159.42

Technical Indicators

Market Signals
Indicator
ONB
DVA
Relative Strength Index (RSI) 42.96 64.44
Support Level $21.89 $146.00
Resistance Level $24.78 N/A
Average True Range (ATR) 0.78 4.39
MACD -0.23 -0.67
Stochastic Oscillator 34.08 47.08

Price Performance

Historical Comparison
ONB
DVA

About ONB Old National Bancorp

Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: